STAT3 and glioblastoma: In patients that succumb to GBM between 5–12 months MGMT, perhaps potentiated by STAT3 phosphorylation increases in pre-treatment MGMT steady-state levels, and short patch BER appear to the main means of TMZ chemotherapeutic resistance.